Mufg Americas Holdings Corp Amgen Inc Transaction History

Mufg Americas Holdings Corp

$0
Q3 2023

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 01, 2022	SELL	$224.46 - $253.15 $603,572 - $680,720	-2,689 Reduced 2.21%	119,220 $26.9 Million
Q3 2022 Oct 31, 2022	SELL	$224.46 - $253.15 $603,572 - $680,720	-2,689 Reduced 2.21%	119,220 $26.9 Million
Q2 2022 Dec 01, 2022	BUY	$230.71 - $256.74 $303,383 - $337,613	1,315 Added 1.09%	121,909 $29.7 Million
Q2 2022 Aug 02, 2022	BUY	$230.71 - $256.74 $303,383 - $337,613	1,315 Added 1.09%	121,909 $29.7 Million
Q1 2022 Dec 01, 2022	BUY	$219.27 - $242.57 $2.81 Million - $3.11 Million	12,817 Added 11.89%	120,594 $29.2 Million
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $2.81 Million - $3.11 Million	12,817 Added 11.89%	120,594 $29.2 Million
Q4 2021 Dec 01, 2022	SELL	$198.88 - $227.6 $3.01 Million - $3.44 Million	-15,116 Reduced 12.3%	107,777 $24.2 Million
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $3.01 Million - $3.44 Million	-15,116 Reduced 12.3%	107,777 $24.2 Million
Q3 2021 Dec 01, 2022	BUY	$212.27 - $248.7 $1.74 Million - $2.04 Million	8,191 Added 7.14%	122,893 $26.1 Million
Q3 2021 Nov 05, 2021	BUY	$212.27 - $248.7 $1.74 Million - $2.04 Million	8,191 Added 7.14%	122,893 $26.1 Million
Q2 2021 Dec 01, 2022	BUY	$233.58 - $259.14 $945,298 - $1.05 Million	4,047 Added 3.66%	114,702 $28 Million
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $945,298 - $1.05 Million	4,047 Added 3.66%	114,702 $28 Million
Q1 2021 Dec 01, 2022	BUY	$221.91 - $258.6 $2.11 Million - $2.46 Million	9,519 Added 9.41%	110,655 $27.5 Million
Q1 2021 Apr 30, 2021	BUY	$221.91 - $258.6 $2.11 Million - $2.46 Million	9,519 Added 9.41%	110,655 $27.5 Million
Q4 2020 Dec 01, 2022	BUY	$216.38 - $257.67 $396,840 - $472,566	1,834 Added 1.85%	101,136 $23.3 Million
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $396,840 - $472,566	1,834 Added 1.85%	101,136 $23.3 Million
Q3 2020 Dec 01, 2022	BUY	$234.65 - $260.95 $1.37 Million - $1.52 Million	5,823 Added 6.23%	99,302 $25.2 Million
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $1.37 Million - $1.52 Million	5,823 Added 6.23%	99,302 $25.2 Million
Q2 2020 Dec 01, 2022	SELL	$197.81 - $242.74 $5.09 Million - $6.25 Million	-25,741 Reduced 21.59%	93,479 $22 Million
Q2 2020 Aug 06, 2020	BUY	$197.81 - $242.74 $3.84 Million - $4.71 Million	19,406 Added 26.2%	93,479 $22 Million
Q1 2020 Apr 24, 2020	BUY	$182.24 - $241.7 $4.58 Million - $6.07 Million	25,127 Added 51.34%	74,073 $15 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $342,659 - $440,435	-1,811 Reduced 3.57%	48,946 $11.8 Million
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $411,421 - $492,969	-2,363 Reduced 4.45%	50,757 $9.82 Million
Q2 2019 Aug 09, 2019	SELL	$166.7 - $195.41 $876,008 - $1.03 Million	-5,255 Reduced 9.0%	53,120 $9.79 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $1.31 Million - $1.47 Million	-7,218 Reduced 11.0%	58,375 $11.1 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $490,778 - $572,895	-2,751 Reduced 4.03%	65,593 $12.8 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $833,805 - $940,004	-4,500 Reduced 6.18%	68,344 $0
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $982,849 - $1.1 Million	-5,919 Reduced 7.51%	72,844 $0
Q1 2018 May 07, 2018	SELL	$169.43 - $198.0 $2.46 Million - $2.88 Million	-14,544 Reduced 15.59%	78,763 $13.4 Million
Q4 2017 Feb 08, 2018	BUY	$168.79 - $188.59 $275,802 - $308,156	1,634 Added 1.78%	93,307 $0
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $447,835 - $511,307	-2,677 Reduced 2.84%	91,673 $0
Q2 2017 Aug 07, 2017	BUY	N/A	94,350	94,350 $0

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Americas Holdings Corp with notifications on news.

Account